Charney Laurence N
Transaction: 06/11/2026
BUY
Change
+8,325
Price
Not reported
Filing
06/15/2026
Type
BUY
TG Therapeutics, Inc.
TGTX • Biotechnology
$54.55
▲ +0.02 (+0.04%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$7.46B
Growth
-15.0%
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 72.6%Positive revenue growth · 203.1%Reasonable earnings multiple · 9.62Manageable debt level · 0.4Healthy liquidity · 4.1
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$54.55
Change0.04%
Market Cap$7.46B
52W Range25.28 - 59.30
Beta1.67
Gross Margin83.66%
Oper. Margin20.01%
Profit Margin72.56%
Debt/Eq0.40
Current Ratio4.10
Quick Ratio3.29
Revenue 5Y-15.05%
Price$54.55
Change0.04%
Market Cap$7.46B
52W Range25.28 - 59.30
Beta1.67
Gross Margin83.66%
Oper. Margin20.01%
Profit Margin72.56%
Debt/Eq0.40
Current Ratio4.10
Quick Ratio3.29
Revenue 5Y-15.05%
Target$80.50
Target Upside47.57%
Target Median$80.50
Target Range78.00 - 83.00
Volume2.86M
Avg Volume2.53M
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
68
out of 100
Business Quality
Margins, moat, returns
86/100
Financial Strength
Debt, cash, stability
83/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
51/100
Why this score▼
Stable or improving margins · 72.6%Positive revenue growth · 203.1%Reasonable earnings multiple · 9.62Manageable debt level · 0.4Healthy liquidity · 4.1
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$78.00
Mean
$80.50
Median
$80.50
High
$83.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Echelard Yann
Transaction: 06/11/2026
BUY
Change
+8,325
Price
Not reported
Filing
06/15/2026
Type
BUY
Hoberman Kenneth
Transaction: 06/11/2026
BUY
Change
+8,325
Price
Not reported
Filing
06/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Charney Laurence N | BUY | +8,325 | Not reported | 06/11/2026 | 06/15/2026 |
| Echelard Yann | BUY | +8,325 | Not reported | 06/11/2026 | 06/15/2026 |
| Hoberman Kenneth | BUY | +8,325 | Not reported | 06/11/2026 | 06/15/2026 |
| HUME DANIEL | BUY | +8,325 | Not reported | 06/11/2026 | 06/15/2026 |
| Lonial Sagar | BUY | +8,325 | Not reported | 06/11/2026 | 06/15/2026 |
| Charney Laurence N | SELL | -13,197 | Not reported | 01/29/2026 | 01/29/2026 |
| Charney Laurence N | SELL | -30,000 | Not reported | 01/28/2026 | 01/29/2026 |
| Power Sean A | BUY | +90,000 | Not reported | 01/08/2026 | 01/09/2026 |
| WEISS MICHAEL S | BUY | +622,000 | Not reported | 01/08/2026 | 01/09/2026 |
| Echelard Yann | SELL | -5,000 | $32.57 | 11/24/2025 | 11/25/2025 |
| WEISS MICHAEL S | SELL | -803,717 | Not reported | 11/05/2025 | 11/07/2025 |
| Lonial Sagar | SELL | -20,852 | $32.24 | 09/11/2025 | 09/12/2025 |
| Echelard Yann | SELL | -10,000 | $36.94 | 06/13/2025 | 06/16/2025 |
| Lonial Sagar | BUY | +14,718 | Not reported | 06/12/2025 | 06/16/2025 |
| HUME DANIEL | BUY | +14,718 | Not reported | 06/12/2025 | 06/16/2025 |
| Hoberman Kenneth | BUY | +14,718 | Not reported | 06/12/2025 | 06/16/2025 |
| Charney Laurence N | BUY | +21,408 | Not reported | 06/12/2025 | 06/16/2025 |
| Echelard Yann | BUY | +14,718 | Not reported | 06/12/2025 | 06/16/2025 |
| HUME DANIEL | SELL | -62,459 | Not reported | 03/17/2025 | 03/18/2025 |
| Charney Laurence N | SELL | -6,000 | Not reported | 03/10/2025 | 03/11/2025 |